Mary M. Rozenman
Overview
Mary M. Rozenman received $1M in total compensation, including $252K in salary, at Aimmune Therapeutics in 2015.
Source: SEC filing on April 12, 2016.
Related executives
We found nine more executives who work or worked at Aimmune Therapeutics.
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
Susan Barrowcliffe
Aimmune Therapeutics
General Manager, Europe
Jeffrey Knapp
Aimmune Therapeutics